ArticleCureus2026
Mpox Presenting as an Anorectal Disease: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mpox (monkeypox) is an emerging viral infection with a broad and evolving clinical spectrum that increasingly spans beyond its characteristic cutaneous manifestations. Anorectal manifestations are well recognized in patients with Mpox in recent outbreaks. However, the gastrointestinal (GI) or anorectal symptoms may precede the typical rash, creating significant diagnostic challenges and delaying appropriate infection control measures. We describe a quinquagenarian man with poorly controlled diabetes mellitus who presented with fever, diarrhea, tenesmus, and severe perianal pain. Cross-sectional imaging demonstrated diffuse rectosigmoid inflammation, while endoscopy revealed severe ulcerative proctitis. Initial evaluation favored acute infectious proctitis, and treatment was directed accordingly. However, the subsequent development of disseminated pustular skin lesions prompted consideration of Mpox, which was ultimately confirmed by polymerase chain reaction testing of the lesions. Extensive testing excluded concurrent human immunodeficiency virus (HIV) infection and other common sexually transmitted infections, and rectal biopsy demonstrated nonspecific acute colitis. The patient recovered with supportive management and had complete endoscopic resolution on follow-up colonoscopy. This case illustrates the relevance of considering Mpox in the differential diagnosis of acute proctitis and lower GI symptoms, even before characteristic skin lesions appear. It also underscores the diagnostic value of maintaining a high index of suspicion in patients presenting with severe anorectal disease and points out that diabetes-associated immune dysfunction may play a role in such cases. Early recognition of atypical GI manifestations is essential for timely diagnosis, appropriate patient isolation, avoidance of unnecessary interventions, and optimal clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.